Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$12.89
-10.0%
$11.04
$8.27
$30.10
$429.45M1.31683,065 shs625,013 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$10.67
-1.1%
$10.59
$8.12
$17.35
$372.49M0.54467,322 shs586,788 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$18.32
+1.2%
$16.89
$14.42
$23.70
$464.90M1.03141,467 shs83,242 shs
Avita Medical Inc. stock logo
RCEL
Avita Medical
$4.18
-4.1%
$4.36
$3.22
$7.12
$134.19M1.87284,591 shs297,655 shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
+7.67%+16.99%+29.01%+43.20%+10.24%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
+4.45%-1.46%-6.42%+18.83%-34.13%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
+6.97%+1.63%+6.22%+0.28%-10.04%
Avita Medical Inc. stock logo
RCEL
Avita Medical
+4.81%-0.68%+2.83%-8.21%-26.48%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$12.89
-10.0%
$11.04
$8.27
$30.10
$429.45M1.31683,065 shs625,013 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$10.67
-1.1%
$10.59
$8.12
$17.35
$372.49M0.54467,322 shs586,788 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$18.32
+1.2%
$16.89
$14.42
$23.70
$464.90M1.03141,467 shs83,242 shs
Avita Medical Inc. stock logo
RCEL
Avita Medical
$4.18
-4.1%
$4.36
$3.22
$7.12
$134.19M1.87284,591 shs297,655 shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
+7.67%+16.99%+29.01%+43.20%+10.24%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
+4.45%-1.46%-6.42%+18.83%-34.13%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
+6.97%+1.63%+6.22%+0.28%-10.04%
Avita Medical Inc. stock logo
RCEL
Avita Medical
+4.81%-0.68%+2.83%-8.21%-26.48%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.33
Hold$18.0039.64% Upside
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
2.43
Hold$22.50110.87% Upside
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.82
Moderate Buy$24.4433.43% Upside
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.33
Hold$7.2573.44% Upside

Current Analyst Ratings Breakdown

Latest RCEL, KIDS, CLPT, and DCTH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
UpgradeHoldBuy$3.50 ➝ $6.00
5/11/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
UpgradeSell (D)Sell (D+)
5/11/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
DowngradeHoldStrong Sell
5/8/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Initiated CoverageBuy$16.00
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$17.00
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingBuy$24.00
4/24/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$25.00
4/21/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingSell (E+)
4/20/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Reiterated RatingSell (D-)
4/8/2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
Reiterated RatingBuy$10.00
3/27/2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
Reiterated RatingSell (E+)
(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$36.97M10.46N/AN/A$0.99 per share13.02
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$85.23M4.32$0.05 per share206.41$3.15 per share3.39
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$236.35M1.99$0.17 per share108.85$13.82 per share1.33
Avita Medical Inc. stock logo
RCEL
Avita Medical
$71.61M1.80N/AN/A($0.55) per share-7.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$25.54M-$1.01N/AN/AN/A-71.57%-140.96%-36.98%8/11/2026 (Estimated)
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$2.70M$0.011,067.00N/AN/A0.62%0.51%0.46%8/5/2026 (Estimated)
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$39.65M-$1.68N/AN/AN/A-16.31%-7.01%-4.86%8/4/2026 (Estimated)
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$48.59M-$1.57N/AN/AN/A-62.67%N/A-78.92%8/6/2026 (Estimated)

Latest RCEL, KIDS, CLPT, and DCTH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2026Q1 2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$0.35-$0.35N/A-$7.00$18.30 million$19.25 million
5/13/2026Q1 2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.28-$0.32-$0.04-$0.32$11.97 million$12.13 million
5/7/2026Q1 2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.0971-$0.03+$0.0671-$0.03$23.51 million$24.99 million
4/30/2026Q1 2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.4552-$0.42+$0.0352-$0.45$58.29 million$59.36 million
3/17/2026Q4 2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.22-$0.27-$0.05-$0.27$10.40 million$10.41 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.63
5.79
4.88
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
11.24
10.33
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.29
5.21
2.37
Avita Medical Inc. stock logo
RCEL
Avita Medical
N/A
0.47
0.38

Institutional Ownership

CompanyInstitutional Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
Avita Medical Inc. stock logo
RCEL
Avita Medical
27.66%

Insider Ownership

CompanyInsider Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.94%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
19.36%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
32.70%
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11029.99 million27.91 millionOptionable
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
6034.52 million27.84 millionOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
20025.68 million17.29 millionOptionable
Avita Medical Inc. stock logo
RCEL
Avita Medical
13030.78 million29.92 millionOptionable

Recent News About These Companies

Avita Medical (NASDAQ:RCEL) Director Buys $43,000.00 in Stock
AVITA Medical to Host Investor Webinar Briefing
BTIG Reaffirms Their Hold Rating on Avita Medical (RCEL)
Avita (RCEL) Q1 2026 Earnings Call Transcript
Avita Medical Q1 Earnings Call Highlights
AVITA Medical Names Cary Vance as Chief Executive Officer

New MarketBeat Followers Over Time

Media Sentiment Over Time

ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$12.89 -1.43 (-9.99%)
Closing price 04:00 PM Eastern
Extended Trading
$12.80 -0.09 (-0.67%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Delcath Systems stock logo

Delcath Systems NASDAQ:DCTH

$10.67 -0.12 (-1.11%)
Closing price 04:00 PM Eastern
Extended Trading
$10.76 +0.10 (+0.89%)
As of 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

OrthoPediatrics stock logo

OrthoPediatrics NASDAQ:KIDS

$18.32 +0.22 (+1.22%)
Closing price 04:00 PM Eastern
Extended Trading
$18.34 +0.02 (+0.11%)
As of 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Avita Medical stock logo

Avita Medical NASDAQ:RCEL

$4.18 -0.18 (-4.13%)
Closing price 04:00 PM Eastern
Extended Trading
$4.24 +0.06 (+1.53%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.